Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imad Sheiban

Showing results (21-30 of 211) with videos related to

Pageof 22
Sort By:
Expert Opinion on Drug Safety|September 2, 2008
Safety of drug-coated stentsGiuseppe Gl Biondi-Zoccai, Claudio Moretti, Marzia Lotrionte, et al.
European Heart Journal|November 13, 2007
Comparison of different methods of measurement of aspirin resistance: using the appropriate statisticMarzia Lotrionte, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.
European Heart Journal|September 4, 2007
Comment on the 'pilot' GRACIA-2 randomized trialGianluca Villata, Mario Bollati, Alfonso Gambino, et al.
Heart International|October 24, 2022
Side Branch is the Main Determinant Factor of Bifurcation Lesion Complexity: Critical Review with a Proposal Based on Single-centre ExperienceImad Sheiban, Filippo Figini, Valeria Gasparetto, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|November 24, 2004
Drug-eluting stent implantation in primary angioplasty of an anomalous left main coronary artery: diagnostic and technical considerationsImad Sheiban, Claudio Moretti, Filippo Sciuto, et al.
Vascular Health and Risk Management|July 17, 2008
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Imad Sheiban, Gianluca Villata, Mario Bollati, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2009
Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stentsGiuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, Claudio Moretti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 13, 2008
Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?Mario Bollati, Giuseppe G L Biondi-Zoccai, Alfonso Gambino, et al.
Journal of Psychopharmacology (Oxford, England)|December 8, 2009
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysisMarianna Mazza, Marzia Lotrionte, Giuseppe Biondi-Zoccai, et al.
Journal of Interventional Cardiology|April 22, 2009
Update on dedicated bifurcation stentsImad Sheiban, Pierluigi Omedé, Giuseppe Biondi-Zoccai, et al.
Pageof 22

Showing results (21-30 of 211) with videos related to

Sort By:
Pageof 22
Expert Opinion on Drug Safety|September 2, 2008
Safety of drug-coated stentsGiuseppe Gl Biondi-Zoccai, Claudio Moretti, Marzia Lotrionte, et al.
European Heart Journal|November 13, 2007
Comparison of different methods of measurement of aspirin resistance: using the appropriate statisticMarzia Lotrionte, Giuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, et al.
European Heart Journal|September 4, 2007
Comment on the 'pilot' GRACIA-2 randomized trialGianluca Villata, Mario Bollati, Alfonso Gambino, et al.
Heart International|October 24, 2022
Side Branch is the Main Determinant Factor of Bifurcation Lesion Complexity: Critical Review with a Proposal Based on Single-centre ExperienceImad Sheiban, Filippo Figini, Valeria Gasparetto, et al.
Italian Heart Journal : Official Journal of the Italian Federation of Cardiology|November 24, 2004
Drug-eluting stent implantation in primary angioplasty of an anomalous left main coronary artery: diagnostic and technical considerationsImad Sheiban, Claudio Moretti, Filippo Sciuto, et al.
Vascular Health and Risk Management|July 17, 2008
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Imad Sheiban, Gianluca Villata, Mario Bollati, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 10, 2009
Making sense of the recent meta-analytical confusion concerning the safety of drug-eluting stentsGiuseppe G L Biondi-Zoccai, Pierfrancesco Agostoni, Claudio Moretti, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 13, 2008
Very very late thrombosis of a sirolimus-eluting stent: does suboptimal stent expansion take its toll even after three years?Mario Bollati, Giuseppe G L Biondi-Zoccai, Alfonso Gambino, et al.
Journal of Psychopharmacology (Oxford, England)|December 8, 2009
Selective serotonin reuptake inhibitors provide significant lower re-hospitalization rates in patients recovering from acute coronary syndromes: evidence from a meta-analysisMarianna Mazza, Marzia Lotrionte, Giuseppe Biondi-Zoccai, et al.
Journal of Interventional Cardiology|April 22, 2009
Update on dedicated bifurcation stentsImad Sheiban, Pierluigi Omedé, Giuseppe Biondi-Zoccai, et al.
Pageof 22